Agilent Receives Approval for First PD-L1 Companion Diagnostic in China SANTA CLARA, Calif., October 2, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the National Medical Products Administration (NMPA, formerly the China Food and Drug Administration) has approved its PD-L1 IHC 22C3 pharmDx assay for use in China. The assay is now approved as... Read more
Basel, 30 September 2019 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares... Read more
This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more
Powering industry-leading CyTOF technology to deliver new insights in translational and clinical research SOUTH SAN FRANCISCO, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has launched seven new cadmium metal labeling kits for use with mass cytometry. The newly available... Read more
Partnering with multiple companies to develop targeted PET imaging tracers to better predict and monitor individual patient response to immunotherapies PET tracers would help increase patient response rates which currently average between 20-40% Initially PET tracers would support pharma companies to enhance clinical trials enabling speed-to-market for immunotherapies Chalfont St Giles, UK –September 24 2019... Read more
Basel, 23 September 2019 Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress First positive results from a Phase III cancer immunotherapy combination study in people with previously untreated advanced bladder cancer First results from the BFAST study testing Foundation Medicine’s FoundationOne® Liquid biopsy assay... Read more
Sep 18, 2019 For the third time in five years, Fortune has named BD to its list of companies that are Changing the World , this year recognizing the company for its significant global efforts and investments to combat antimicrobial resistance (AMR) in the areas of infection prevention, diagnostics, surveillance and reporting. Through its decades of experience in collaborating to... Read more
HILLERØD, 11. September, 2019. FOSS and DTU, Technical University of Denmark, join forces around common interests within research, development and education. A new strategic partnership between DTU and FOSS will strengthen the existing relations within research, development and education. The aim is to create a platform for common projects and goals, and to ensure a... Read more
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has filed new legal action in the United States District Court for the Northern District of Californiaseeking to stop the infringement of its patented technology by IONpath. In... Read more
San Jose, Calif. – (September 3, 2019) – Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications. Bringing together... Read more